NCT06458257View on ClinicalTrials.gov

The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 19, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
Acute Myeloid Leukemia
Interventions
PROCEDURE

Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation

DRUG

Chemotherapy

Chemotherapy

Trial Locations (1)

200025

RECRUITING

Ruijin Hospital Affiliated to Shanghai Jiaotong University School Of Medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER